Sample Size Based on Pharmacodynamic endpoints [Power / Sample Size]

posted by nobody – 2019-04-05 10:37 (1905 d 04:01 ago) – Posting: # 20124
Views: 3,885

❝ The fact that it is also a royal waste of money is of course only secondary.


Full-blown development mode. Accept it. Tell the sponsor you can't do the trial, if you are not qualified for PD-endpoint testing.

Kindest regards, nobody

Complete thread:

UA Flag
Activity
 Admin contact
23,059 posts in 4,841 threads, 1,649 registered users;
49 visitors (0 registered, 49 guests [including 4 identified bots]).
Forum time: 14:38 CEST (Europe/Vienna)

There are only two kinds of scholars;
those who love ideas and those who hate them.    Emile Chartier

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5